BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29753718)

  • 1. Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner.
    Buenrostro D; Kwakwa KA; Putnam NE; Merkel AR; Johnson JR; Cassat JE; Sterling JA
    Bone; 2018 Aug; 113():77-88. PubMed ID: 29753718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone-related protein and bone metastases.
    Guise TA
    Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer.
    Nam JS; Suchar AM; Kang MJ; Stuelten CH; Tang B; Michalowska AM; Fisher LW; Fedarko NS; Jain A; Pinkas J; Lonning S; Wakefield LM
    Cancer Res; 2006 Jun; 66(12):6327-35. PubMed ID: 16778210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.
    Nyman JS; Merkel AR; Uppuganti S; Nayak B; Rowland B; Makowski AJ; Oyajobi BO; Sterling JA
    Bone; 2016 Oct; 91():81-91. PubMed ID: 27423464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation.
    Futakuchi M; Nannuru KC; Varney ML; Sadanandam A; Nakao K; Asai K; Shirai T; Sato SY; Singh RK
    Cancer Sci; 2009 Jan; 100(1):71-81. PubMed ID: 19038005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
    Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
    Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
    Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
    Kominsky SL; Doucet M; Brady K; Weber KL
    J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of lethally irradiated adult mice with dominant negative TGF-beta type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory disease.
    Shah AH; Tabayoyong WB; Kimm SY; Kim SJ; Van Parijs L; Lee C
    J Immunol; 2002 Oct; 169(7):3485-91. PubMed ID: 12244137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
    Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
    Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
    Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis.
    Pollari S; Käkönen RS; Mohammad KS; Rissanen JP; Halleen JM; Wärri A; Nissinen L; Pihlavisto M; Marjamäki A; Perälä M; Guise TA; Kallioniemi O; Käkönen SM
    Mol Cancer Res; 2012 May; 10(5):597-604. PubMed ID: 22522458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β signaling in myeloid cells is required for tumor metastasis.
    Pang Y; Gara SK; Achyut BR; Li Z; Yan HH; Day CP; Weiss JM; Trinchieri G; Morris JC; Yang L
    Cancer Discov; 2013 Aug; 3(8):936-51. PubMed ID: 23661553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
    Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line.
    Ehata S; Hanyu A; Fujime M; Katsuno Y; Fukunaga E; Goto K; Ishikawa Y; Nomura K; Yokoo H; Shimizu T; Ogata E; Miyazono K; Shimizu K; Imamura T
    Cancer Sci; 2007 Jan; 98(1):127-33. PubMed ID: 17129361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
    J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment.
    Futakuchi M; Lami K; Tachibana Y; Yamamoto Y; Furukawa M; Fukuoka J
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31619018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
    Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
    J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.